ROCHESTER, N.Y. — Turbett Surgical has appointed Kevin Danahy as president and chief executive officer, naming him to lead the company through its next phase of clinical expansion and commercial growth.
Danahy joins the medical technology company after serving in senior executive roles at Pulse Biosciences, including president and CEO, during the company’s transition toward a cardiac and oncology focus. He previously was president and CEO of private equity-backed Solmetex, where he rebuilt the executive leadership team and helped lead the company to an exit.
Danahy also spent more than two decades in leadership roles at medical device companies including Zimmer Biomet, Intuitive Surgical and Medtronic.
“Kevin brings a track record of building high growth, customer-focused organizations to Turbett and we believe that his experience will enhance their mission of expanding the US and international reach of this innovative product,” said Joe Siletto, Co-Managing Partner of J.P. Morgan Life Sciences Private Capital and Chairman of the Board at Turbett. “Kevin has proven his ability to build teams while focusing on customer needs and patient outcomes, and we are thrilled for him to bring his unique leadership style to guide Turbett in its future success.”
Turbett said Danahy will focus on building a high-performance culture while expanding the company’s reach among surgeons, nursing staff, sterile processing teams and hospital professionals in the U.S. and internationally.
“Turbett Surgical represents the perfect fit for my leadership experience, combining a foundation of technical innovation with an immense opportunity to scale through a culture of excellence. My mission is to cultivate a success-driven environment where every individual feels a connection to our work. I have learned from the best organizations in the world that true market dominance isn’t just about the product; it’s about the passion, skill, and alignment of the team behind it. I am excited to inspire this talented group to reach new heights, exceed our growth expectations, and ultimately transform the way we serve our extremely important customer base of surgeons, nursing staff, sterile processing and hospital professionals globally.”
